Strides Pharma gains on transfer of Bengaluru facility to Syngene
- Hot Stocks
admin
- 0
- 1 minute read
Stelis and Syngene have executed the final agreements to transfer its Unit 3 multi-modal facility in Bengaluru to Syngene with gross consideration adjusted from Rs 702 crore to Rs 617 crore.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1190222745-b65de6b6c3b948d2a22db5d28c5b1fb8.jpg "Is My Credit Score Good Enough for a Mortgage?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1390654298-5468501d88fb4e7faca533096301f91c-10635296cf604385879a8a0cdb404622.jpg "Best Strategies for Your Roth 401(k)")
:max_bytes(150000):strip_icc():format(jpeg)/socialsecurity-whentoapply-794e7d2e1615450a9c7530288e2f5dad.jpg "Unlocking Benefits: The Best Time to Apply for Social Security")